486414-86-2

Basic information

• Product Name: (1-METHYL-1H-IMIDAZOL-5-YL)METHYLAMINE
• Synonyms: 1-METHYL-5-AMINOMETHYLIMIDAZOLE;(1-METHYL-1H-IMIDAZOL-5-YL)METHYLAMINE;1-Methyl-5-aminomethylimidazole 97%;1-Methyl-5-aMinoMethyliMi...;(1-Methyl-1H-iMidazol-5-yl)MethanaMine;5-(Aminomethyl)-1-methyl-1H-imidazole 97%;5-(Aminomethyl)-1-methyl-1H-imidazole97%;C-(3-METHYL-3H-IMIDAZOL-4-YL)-METHYLAMINE
• CAS NO: 486414-86-2
• Molecular Formula: C5H9N3
• Molecular Weight: 111.15
• Mol File: 486414-86-2.mol

Chemical Properties

• Boiling Point: 100 °C
• Flash Point: 130.5 °C
• Appearance: /
• Density: 1.16 g/cm³
• Vapor Pressure: 0.00186mmHg at 25°C
• Refractive Index: 1.579
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• PKA: 9.38±0.29(Predicted)
• CAS DataBase Reference: (1-METHYL-1H-IMIDAZOL-5-YL)METHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: (1-METHYL-1H-IMIDAZOL-5-YL)METHYLAMINE(486414-86-2)
• EPA Substance Registry System: (1-METHYL-1H-IMIDAZOL-5-YL)METHYLAMINE(486414-86-2)

Safety Data

• Hazard Codes: C,Xi
• Statements: 34-41-37/38
• Safety Statements: 26-36/37/39-39
• RIDADR: 2735
• Hazardous Substances Data: 486414-86-2(Hazardous Substances Data)

Usage

Uses

1-Methyl-5-aminomethylimidazole (cas# 486414-86-2) is a compound useful in organic synthesis.

InChI:InChI=1/C5H9N3/c1-8-4-7-3-5(8)2-6/h3-4H,2,6H2,1H3

Upstream product

• 41806-40-0 1-methyl-1H-imidazole-5-carboxylic acid 
• 40637-81-8 3-methyl-3H-imidazole-4-carboxylic acid amide 

Downstream Products

• 1019253-57-6 5-butyl-N-((1-methyl-1H-imidazol-5-yl)methyl)-1-(5-methyl-4-phenoxypyrimidin-2-yl)-1H-pyrazole-4-carboxamide 

Relevant articles and documents

SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF

Provided herein are small molecule activators of Nicotinamide Phosphoribosyltransferase (NAMPT), compositions comprising the compounds, and methods of using the compounds and compositions.

ANTIPROLIFERATIVE 2-(SULFO-PHENYL)-AMINOTHIAZOLE DERIVATIVES

Aminothiazole compounds substituted with sulfur-containing groups are represented by the Formula (I), and their pharmaceutically acceptable salts, prodrugs, active metabolites, and pharmaceutically acceptable salts of said metabolites are described. These agents modulate and/or inhibit the cell proliferation and activity of protein kinases and are useful as pharmaceuticals for treating malignancies and other disorders.

NOVEL COMPOUNDS

Compounds of formula (I) wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents -(CRnaRnb)n-; Rna and Rnb are each independently hydrogen or C1-6alkyl; n is an integer from 0 to 5;R2 represents unsubstituted or substituted aryl or un

Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use

Aminothiazole compounds with mono-/di-substituted benzamide are represented by the Formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, pharmaceutically active metabolites, and pharmaceutically acceptable salts of said metabolites are described. These agents modulate and/or inhibit the cell proliferation and activity of protein kinases and are useful as pharmaceuticals for treating malignancies and other disorders.